Concord Biotech Limited (BOM:543960)

Concord Biotech Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Concord Biotech stock has a consensus rating of "Buy" and an average price target of ₹1,196. The average 1-year stock price forecast is 0.35% lower than the current stock price, while the lowest is ₹1,020 (-15.01%) and the highest is ₹1,380 (+14.98%).

Price Target: ₹1,196 (-0.35%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	₹1,020	₹1,196	₹1,260	₹1,380
Change	-15.01%	-0.35%	+4.98%	+14.98%

Analyst Ratings

The average analyst rating for Concord Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Apr '26
Strong Buy	3	2	2	2	2	2
Buy	1	2	2	2	2	2
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	5

Financial Forecast

Revenue This Year

12.36B

Increased by 17.17%

from 10.55B

Revenue Next Year

15.64B

Increased by 26.54%

from 12.36B

EPS This Year

33.48

Increased by 35.09%

from 24.78

EPS Next Year

46.21

Increased by 38.04%

from 33.48

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	7.13B	8.53B	10.17B	12.00B	10.55B	12.36B
Revenue Growth	15.56%	19.67%	19.20%	18.01%	-12.10%	17.17%
Gross Profit	5.41B	6.61B	6.67B	7.68B	6.93B	9.41B
Gross Margin	75.89%	77.49%	65.61%	64.03%	65.70%	76.10%
Operating Income	2.29B	3.00B	3.87B	4.60B	2.93B	3.74B
Net Income	1.75B	2.40B	3.08B	3.72B	2.61B	3.50B
EPS	16.72	22.95	29.45	35.52	24.78	33.48
EPS Growth	-25.52%	37.25%	28.33%	20.62%	-30.25%	35.09%
Forward PE	-	-	-	-	-	35.85
Dividend / Share	5.12	6.83	8.75	10.70	7.55	12.53
Dividend Growth	-	33.40%	28.11%	22.29%	-29.44%	65.89%
Free Cash Flow	188.91M	505.95M	1.18B	926.14M	1.14B	2.63B
No. Analysts	-	-	-	-	-	3

Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	12.7B
Avg	12.4B
Low	12.1B

Revenue Growth

Revenue Growth	2027	2028	2029
High	20.0%
Avg	17.2%
Low	15.0%

EPS Forecast

EPS	2027	2028	2029
High	34.00
Avg	33.48
Low	32.95

EPS Growth

EPS Growth	2027	2028	2029
High	37.2%
Avg	35.1%
Low	33.0%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.